JuanCarlosBandresMD

Infectious Disease • Bronx, NY

Assistant Professor, Medicine, Icahn School of Medicine

Join to view full profile

Dr. Bandres is on Doximity

As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.

Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
Connect with colleagues in the same hospital or clinic.
Read the latest clinical news, personalized to your specialty.

See Dr. Bandres' full profile

Already have an account?

Office
130 W Kingsbridge Rd
Bronx, NY 10468
Phone+1 718-584-9000

Fax+1 718-741-4606

Education & Training

Baylor College of MedicineFellowship, Infectious Disease, 1990 - 1992
University of Texas Health Science Center at HoustonResidency, Internal Medicine, 1987 - 1990
Complutense University of MadridClass of 1983

Certifications & Licensure

MO State Medical License 1996 - 2026

Clinical Trials

Comparing the Efficacy, Safety, and Tolerability of Combination Antivirals (Amantadine, Ribavirin, Oseltamivir) Versus Oseltamivir for the Treatment of Influenza in Adults at Risk for Complications Start of enrollment: 2010 Sep 01
Completed
Phase 2

Publications & Presentations

PubMed

Heterologous Ad26/Ad5 adenovirus-vectored vaccines elicited SARS-CoV-2-specific antibody responses with potent Fc activities.
Jéromine Klingler, Shreyas Kowdle, Juan C Bandres, Rozita Emami-Gorizi, Raymond A Alvarez
Frontiers in Immunology. 2024-01-01
3 citations
Immune profiles to distinguish hospitalized versus ambulatory COVID-19 cases in older patients.
Jéromine Klingler, Gregory S Lambert, Juan C Bandres, Rozita Emami-Gorizi, Arthur Nádas
Iscience. 2022-12-22
10 citations
SARS-CoV-2 mRNA vaccines induce a greater array of spike-specific antibody isotypes with more potent complement binding capacity than natural infection
J eacuteromine Klingler, Gregory S. Lambert, Vincenza Itri, Sean T. H. Liu, Juan C. Bandres
Medrxiv. 2021-05-17